Home
Pharm-Olam

Pharm-Olam Market Share Analysis for November 2025

Allucent is a full-service Clinical Research Organization dedicated to providing high quality solutions for small to mid-sized biotechs.

Health > Biotechnology and Pharmaceuticals

Domainpharm-olam.com

Year Founded1994

Employees501 - 1000

Annual Revenue$50M - $75M

Pharm-Olam

Pharm-Olam (including company regionals)

pharm-olam.com

See more website traffic and engagement information

Pharm-Olam Revenue up to November 2025 is 50M - 75M

revenue generated by Pharm-Olam top domains

Pharm-Olam top domains revenue over 3 years

Revenue for Pharm-Olam top domains

pharm-olam.com50M - 75M

See more with Sales Intelligence

Total visits to Pharm-Olam's top domains

Understand Pharm-Olam market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Pharm-Olam's top domains

Analyze Pharm-Olam engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Pharm-Olam's top domains

See how Pharm-Olam keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Pharm-Olam top competitors by domain

Top similar sites in November 2025, ranked by their affinity

lotuslabs.comCompany NameLotus LabsEmployees201 - 500HQIndia, Bangalore G.P.O.Annual revenue$50M - $75MTotal visits1.3KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Pharm-Olam

These are the website technologies, by industry, used by Pharm-Olam top domains

Advertising (10)

DoubleClick

Content Management System (5)

WordPress

Conversion & Analytics (4)

Google Analytics

Audio Video Media (3)

YouTube

More Technologies

10

See all

News & Signals from Pharm-Olam

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCato Sms merged with Pharm-Olam on Jan 12th '22.CATO SMS, a Triangle-based clinical research organization, is getting larger, merging with U.K.-based Pharm-Olam in a deal announced early Wednesday.

NewsPharm-Olam partners with Valneva SE.Dr. Robert J. Davie, Chief Executive Officer said: "Pharm-Olam is delighted to partner with Valneva in their on-going clinical development programme for the tremendously important SARS-CoV-2 vaccine candidate, VLA2001.

NewsPharm-Olam signed new client U.S. Department of Defense on Jan 19th '21.Pharm-Olam, a global mid-sized clinical research organization (CRO), has been selected by the U.S. Department of Defense's (DOD) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) to lead and provide full service clinical trial support of the Adalimumab COVID Therapeutic Trial.